J. F. HARRISON, R. W. PARKER, AND K. L. DE SILVA From Selly Oak Hospital, Birmingham SYNOPSIS On the assumption that increased urinary lysozyme concentration ('lysozymuria') indicates tubular proteinuria and therefore impaired tubular function, urinary lysozyme has been estimated in acute disorders where transient disturbances of renal function might be expected, in cases diagnosed clinically as extrarenal uraemia, and in a few examples of acute renal disease. Reversible lysozymuria occurred with hypokalaemia, postoperative 'collapse', electrolyte depletion, severe extrarenal infection, acute pyelonephritis, the nephrotic syndrome, after a few apparently uncomplicated surgical operations, and very transiently after ventricular fibrillation abolished by DC shock. There was no lysozymuria with severe uraemic heart failure, aspirin and paracetamol poisoning, or severe jaundice, nor in two cases of acute glomerulonephritis. Although lysozymuria may occasionally be useful in the clinical diagnosis of acutely disordered renal function, the results suggest that its value is limited; on the other hand, they have provided information on renal pathophysiology in acute disease.
There is good evidence that the excretion of low molecular weight proteins is increased when renal tubular function is impaired (Flynn and Platt, 1968) ; the result is 'tubular proteinuria'. Different low molecular weight proteins seem to follow the same pattern of urinary excretion in health and disease (Harrison, Lunt, Scott, and Blainey, 1968) . These proteins all pass more or less readily into the glomerular filtrate and are believed then to be reabsorbed, mainly if not entirely in the proximal tubules, so that they scarcely appear in normal urine. Decreased tubular reabsorption will therefore cause an increase in their urinary concentration, and when this occurs it is probably due to generalized tubular cell damage since specific defects of tubular protein transport have not so far been described.
Lysozyme (molecular weight 15 000) is such a protein; its assay happens to be simple, sensitive, and subject to few complicating factors, and in some circumstances urinary lysozyme concentration can be one of the most useful indices of tubular function (Adams, Harrison, and Scott, 1969) . Lysozyme in the blood probably originates in the leucocytes (Jolles, Steinberg, and Mathe, 1965) protein. There is so far no evidence that lysozyme is secreted into the urinary tract; pyuria might be expected to increase the urinary lysozyme concentration, but any effect there may be has so far proved to be very slight (Barratt and Crawford, 1970) . Nevertheless to establish that lysozymuria is due to impaired tubular reabsorption it is necessary to know that the normal renal threshold is not exceeded, because when this occurs, as in some forms of leukaemia, there is 'overflow' lysozymuria analogous to the glycosuria of diabetes (Osserman and Lawlor, 1966) .
In renal disease, tubular proteinuria and lysozymuria were first described in relation to chronic disorders of function (Prockop and Davidson, 1964) ; both are always found in advanced chronic renal failure and are useful in the diagnosis of cadmium nephropathy. Acute, reversible tubular proteinuria and lysozymuria have been reported in acute tubular necrosis (Revillard and Manuel, 1965; Noble and Brainerd, 1966; Maiorca and Scarpioni, 1968; Hayslett, Perillie, and Finch, 1968; Wauters and Favre, 1970) , as a sign of renal transplant rejection (Shehadeh, Carpenter, Monterio, and Merrill, 1970; Hansen and Weeke, 1970; Harrison, Barnes, and Blainey, 1972) , and after exercise (Poortmans, 1972) . The present study was undertaken to find out whether lysozymuria is common among non-oliguric patients in ordinary hospital wards, by studying three main groups of cases: (a) patients with con-ditions which when severe or complicated might be expected to cause tubular damage; (b) patients with a clinical diagnosis of extrarenal uraemia; and (c) a few patients with acute renal disease.
Method
The assay was a modification of the method of Smolelis and Hartsell (1949) . The substrate was a suspension of Micrococcus lysodeikticus cells (Sigma Chemical Co), 25 mg/ml. Sodium phosphate buffer, pH 6-2, 0-067 M, was used for diluting the substrate and standards. Samples of 0-5 ml were added to 5 0 ml substrate suspension; optical densities at 450 nm were measured at 0 5 min and 10 min, and the reaction was allowed to proceed at 37°. The difference between the OD readings was referred to a standard curve constructed from samples containing eggwhite lysozyme in buffer (Seravac Laboratories) covering the range 1 0-20-0,ug/ml. Urineswere diluted if necessary; to avoid the inhibitory effect of macromolecules in serum (Harrison and Swingler, 1971 ) all sera were diluted 1 in 8 routinely before estimation. For lysozyme in urine the coefficient of variation was 7 %. Lysozyme activity was expressed as ,ug/ml egg-white lysozyme, but since human lysozyme has about 3-5 times the activity of egg-white lysozyme (Jolles and Jolles, 1967 ) the figures do not represent true concentrations.
Normal Values
In an earlier study (Harrison et al, 1968) from 24 estimations each the normal range for serum lysozyme was considered to be 5-1-14 ,ug/ml, and that for urine was 0-07-1 1 ug/ml. Using the present slightly modified method and random 'normal' specimens arriving in the hospital biochemistry laboratory, the normal range was 9-4 ± SD 2-7 ,ug/ml for serum (55 estimations), and 0 7 ± SD 0-6 ,ug/ml for urine (82 estimations). We have therefore defined 'lysozymuria' as a urine lysozyme concentration greater than 1 9 ,ug/ml.
Evidence that Lysozymuria Was Not Caused by Serum Lysozyme Levels above the Normal Renal Threshold
The normal renal threshold for lysozyme is not easy to determine. There have been no studies based on lysozyme infusions to raise the serum concentration in human subjects. Experiments with egg-white lysozyme infused into dogs (Harrison and Barnes, 1970) have suggested a threshold corresponding to 32-56 ,ug/ml for human lysozyme, allowing for the difference in activity of the two lysozymes, but canine and human thresholds may not be the same. Since very high levels are found in leukaemia it should be possible to deduce the threshold using data from leukaemic patients. In this way there have been various estimates: 45 ,ug/ml (Hayslett et al, 1968) , more than 50 ,tg/ml (Perillie, Kaplan, Lefkowitz, Rogaway, and Finch, 1968) , and variable butnot less than 42 ,tg/ml (Wiernik and Serpick, 1969) .
Our own data from patients with leukaemia do not give conclusive evidence: they are shown in figure 1. Abnormally high urinary lysozymes occurred with serum levels as low as 18 ,ug/ml; they were presumably due to renal tubular defects since normal urinary excretion occurred with serum concentrations up to 52 ,jg/ml. Pruzanski and Platts (1970) have similarly found evidence of tubular dysfunction in leukaemia. Peterson, Evrin, and Berggard (1969) .
Like other proteins, reabsorbed lysozyme is catabolized in the renal tubules, so that lysozyme which passes into the glomerular filtrate is 'lost' to the circulation whether it is excreted in the urine or not (Harrison and Barnes, 1970) . The serum lysozyme concentration accordingly depends on the glomerular filtration rate but not on tubular function; in consequence, it tends to rise with advancing azotaemia. Some patients with renal failure might therefore be expected to have lysozymuria because of 'overflow' without necessarily a disproportionate loss of tubular function. In fact nearly all the patients described above had serum lysozyme levels below 45 ,ug/ml, and there was no correlation between urinary lysozyme and the concentration ofcreatinine, urea, or lysozyme in serum. Combining the results from these patients with a larger, also miscellaneous group, some of whom had advanced chronic renal failure, among 263 estimations of serum lysozyme there were only seven with levels above 45 ,ug/ml and only four with levels above 50 ,tg/ml: these four included three specimens from three patients with dehydration (one of whom is included in table IV), and a specimen from a patient with hyperosmolar diabetic coma. High serum lysozymes also occur in the early stages of acute tubular necrosis (Hayslett et al, 1968; Harrison et at, 1972) . Under these circumstances, lysozymuria may not necessarily be due to impaired tubular reabsorption. Therefore when evidence of tubular damage is sought by estimating the urinary lysozyme, strictly the serum lysozyme should also be known, although in most clinical circumstances the chances are very high that it will be below the normal threshold.
A (Harrison et al, 1972) . We did not think it would help to measure the excretion rate or the clearance of lysozyme instead of the urine concentration, mainly because there is so little lysozyme in normal urine: the observed increases in lysozyme excretion were mostly so great that the extra information given by these more complicated estimates would have been hardly significant. The results are perhaps of more interest in helping to understand renal pathophysiology in acute disease, and particularly in showing the vulnerability of renal tubular cells to impairment of their function. Whatever the exact nature of the tubular abnormalities, the causes must have been various. Hypokalaemia is a well known cause of tubular lesions and presumably interferes with cell enzymes and transport mechanisms. The way in which dehydration and electrolyte depletion cause damage is less certain: patients in this group had some of the most pronounced lysozymuric episodes, but apart from the patient with diabetic ketosis their serum potassium levels were normal. Some of them excreted the largest amounts of lysozyme during recovery, which is consistent with the hypothesis that they had patchy tubular necrosis with urea retention and localized failure of urine secretion: if this were so, the damaged tubules would have allowed urine to flow again as recovery began, but at first with deficient protein reabsorption. In acute pyelonephritis, oedema, and inflammation of the kidney are likely to have been responsible for tubular damage. The reversible lysozymuria of the nephrotic patients might have been related either to renal oedema or to some kind of intracellular electrolyte imbalance. The cause of the lysozymuria accompanying severe pneumonia and wound infection is also uncertain; perhaps circulating toxins were involved. These cases of infection incidentally suggest that the well recognized proteinuria of acute fevers is due to transient tubular damage. Two surgical patients had lysozymuria without any apparent complication to their operations, and there was no reason to suspect the anaesthetic: again, the cause is obscure.
All these patients contrast with those who had heart disease, most of whom had normal urinary lysozymes even though many of them were azotaemic.
Cardiac arrest (which lasted perhaps 10 minutes in each case before resuscitation) might be expected to cause anoxic tubular damage, but lysozymuria was either absent or slight and of brief duration; it was also an exceptional finding in even the severest cases of heart failure, and these patients' azotaemia could therefore perhaps truly be regarded as 'extrarenal', caused by a low cardiac output. It was also of interest to discover that poisoning with aspirin and paracetamol, and severe but otherwise uncomplicated jaundice, did not appear to cause tubular damage.
